SCHEMBL25975498

SCHEMBL25975498

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4ccc5c(c4)oc4cccc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)c45)cc3)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.33
ALDH1A1 P00352 4/20 0.33
HPGD P15428 4/20 0.33
TSHR P16473 3/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
GAA P10253 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ALOX15 P16050 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33
HCRTR1 O43613 1/20 0.32
CRHR1 P34998 1/20 0.32
KDM4E B2RXH2 4/20 0.32
SMN1; SMN2 Q16637 4/20 0.32
LMNA P02545 2/20 0.32
GLA P06280 2/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26415577 0.99 TSHR (0.32) MAPTALDH1A1HPGDTSHRMEN1
SCHEMBL25975511 0.99 TSHR (0.32) MAPTALDH1A1HPGDTSHRMEN1
SCHEMBL24255609 0.99 TSHR (0.32) MAPTALDH1A1HPGDTSHRMEN1
SCHEMBL26415564 0.99 TSHR (0.32) MAPTALDH1A1HPGDTSHRMEN1
SCHEMBL25975513 0.96 HCRTR1 (0.35) MAPTALDH1A1HPGDTSHRKMT2A
SCHEMBL26420450 0.95 MAPT (0.33) MAPTALDH1A1HPGDTSHRMEN1
SCHEMBL24255593 0.95 MAPT (0.34) MAPTALDH1A1HPGDTSHRMEN1
SCHEMBL25975494 0.94 MAPT (0.32) MAPTALDH1A1HPGDTSHRMEN1
SCHEMBL24255591 0.94 MAPT (0.33) MAPTALDH1A1HPGDTSHRMEN1
SCHEMBL24255592 0.94 MAPT (0.33) MAPTALDH1A1HPGDTSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023149718-A1 ORGANIC LIGHT-EMITTING ELEMENT INCLUDING HETEROCYCLIC COMPOUND, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING ELEMENT, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING ELEMENT 엘티소재주식회사 2023-08-10 WO disclosed
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 MAPT 950/4885ALDH1A1 27/4885HPGD 1004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.